Recruiting

Atopic Dermatitis

Sponsor:

CorEvitas

Code:

NCT06238765

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 10 - 15

Healthy Volunteers: Accepted

Study Details

Brief summary:

Prospective observational registry for an adolescent cohort with AD under the care of a dermatology provider. Approximately 1500 subjects and 75 clinical sites in North America and select European countries will be recruited to participate with no defined upper limit for either target.

Conditions

Atopic Dermatitis

Study ID

NCT06238765

Start date

Dec 2, 2023

Status verified date

Jun, 2026

Completion date

Dec 31, 2099

Anticipated

Primary completion date

Dec 31, 2099

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 10 - 15

Healthy Volunteers: Accepted

Inclusion Criteria:

  • To be eligible to participate in this registry, an individual must meet all the following criteria:

1. Has been diagnosed with moderate to severe atopic dermatitis by a dermatologist or a qualified healthcare provider
2. Is 10 - 15 years of age at the time of enrollment.
3. Subject has initiated or is initiating an enrollment-eligible medication at the time of enrollment

Exclusion Criteria:
  • An individual who meets any of the following criteria will be excluded from participation in the registry:

1. Is participating or planning to participate in a blinded clinical trial for an AD drug.
2. Is unwilling or unable to provide standing height measurements.

Study Design

Enrollment

1500 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • AD epidemiology, presentation, natural history, management, and outcomes [ Time Frame: Through Study completion until the subject is 18 years ]

Central Contacts and Locations

Locations

CorEvitas, LLC

Recruiting

Waltham, Massachusetts, United States, 02451

Contacts

Cathy Cheney

508-555-1212corevitasregistrytrials@corevitas.com

More Information

Sponsor

CorEvitas

Last update posted

Jun 29, 2026

Last verified

Jun, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by CorEvitas on 2026-06-29.